Stock RCM R1 RCM INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials R1 RCM Inc.

Equities

RCM

US77634L1052

Healthcare Facilities & Services

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
12.86 USD -1.00% Intraday chart for R1 RCM Inc. +3.04% +21.67%
May. 16 Transcript : R1 RCM Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 08:00 AM
May. 14 Deutsche Bank Adjusts R1 RCM Price Target to $14 From $15, Maintains Hold Rating MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,465 2,802 7,046 4,561 4,432 5,417 - -
Enterprise Value (EV) 1 1,727 3,180 7,689 6,237 5,896 7,343 7,045 6,614
P/E ratio -162 x 72.8 x 69.8 x -68.4 x 1,057 x -79.9 x 65.6 x 41 x
Yield - - - - - - - -
Capitalization / Revenue 1.24 x 2.21 x 4.78 x 2.52 x 1.97 x 2.07 x 1.86 x 1.69 x
EV / Revenue 1.46 x 2.5 x 5.21 x 3.45 x 2.62 x 2.81 x 2.41 x 2.06 x
EV / EBITDA 10.3 x 13.3 x 22.4 x 14.7 x 9.6 x 11.4 x 9.18 x 7.57 x
EV / FCF 32.6 x 254 x 36.1 x -60.3 x 24.8 x 40.8 x 26.5 x 16.2 x
FCF Yield 3.06% 0.39% 2.77% -1.66% 4.03% 2.45% 3.78% 6.15%
Price to Book 81.8 x - 20.5 x 1.2 x 1.74 x 1.9 x 1.77 x 1.58 x
Nbr of stocks (in thousands) 112,865 116,662 276,434 416,511 419,308 421,255 - -
Reference price 2 12.98 24.02 25.49 10.95 10.57 12.86 12.86 12.86
Announcement Date 2/20/20 2/18/21 2/17/22 2/16/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,186 1,271 1,475 1,806 2,254 2,612 2,920 3,213
EBITDA 1 168 240 343.6 425.5 614.3 642.4 767.2 873.8
EBIT 1 57.7 80 145.7 3 147.9 98.02 237.3 349.9
Operating Margin 4.86% 6.3% 9.88% 0.17% 6.56% 3.75% 8.13% 10.89%
Earnings before Tax (EBT) 1 9.8 118.4 126.8 -61 21 -77.61 230.6 217.6
Net income 1 -8.7 117.1 97.2 -57.6 3.3 -73.01 79.57 123.5
Net margin -0.73% 9.21% 6.59% -3.19% 0.15% -2.79% 2.73% 3.84%
EPS 2 -0.0800 0.3300 0.3652 -0.1600 0.0100 -0.1610 0.1961 0.3133
Free Cash Flow 1 52.9 12.5 213.1 -103.4 237.6 180.2 266.3 407
FCF margin 4.46% 0.98% 14.45% -5.72% 10.54% 6.9% 9.12% 12.67%
FCF Conversion (EBITDA) 31.49% 5.21% 62.02% - 38.68% 28.05% 34.72% 46.58%
FCF Conversion (Net income) - 10.67% 219.24% - 7,200% - 334.71% 329.69%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/20/20 2/18/21 2/17/22 2/16/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 398.9 385.7 391.9 496 532.8 545.6 560.7 572.8 575.1 603.9 640 658.7 709.7 681.1 720.5
EBITDA 1 95.1 89.3 87.2 124 125 142.2 142.9 161.5 167.7 152.2 153.1 155.1 183.7 173.3 186.5
EBIT 1 50.2 43.2 -38 2 -4.2 33.7 23.9 41.2 49.1 8 19.1 18.15 47.65 44.1 46.65
Operating Margin 12.58% 11.2% -9.7% 0.4% -0.79% 6.18% 4.26% 7.19% 8.54% 1.32% 2.98% 2.76% 6.71% 6.47% 6.47%
Earnings before Tax (EBT) 1 45.1 38.5 -44.9 -21.7 -32.9 3 -8.6 9.1 17.5 -33.3 -26.87 -21.58 2.156 22.54 32.42
Net income 1 36 29.4 -20.4 -29.5 -37.1 0.3 0.3 1.3 1.4 -35.1 -21.94 -21.65 4.535 8.017 16.1
Net margin 9.02% 7.62% -5.21% -5.95% -6.96% 0.05% 0.05% 0.23% 0.24% -5.81% -3.43% -3.29% 0.64% 1.18% 2.23%
EPS 2 0.1100 0.0900 -0.0700 -0.0700 -0.0900 0.000700 - - 0.003100 -0.0800 -0.0481 -0.0406 0.008340 0.0142 0.0335
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 2/17/22 5/9/22 8/3/22 11/8/22 2/16/23 5/4/23 8/2/23 11/2/23 2/27/24 5/8/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 262 378 642 1,676 1,464 1,926 1,627 1,196
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.56 x 1.576 x 1.869 x 3.94 x 2.383 x 2.998 x 2.121 x 1.369 x
Free Cash Flow 1 52.9 12.5 213 -103 238 180 266 407
ROE (net income / shareholders' equity) 98.4% 108% 44.7% -3.76% 0.12% -0.83% 2.9% 4.15%
ROA (Net income/ Total Assets) 9.84% 5.38% 7.37% -1.75% 0.07% -1.27% 0.12% 1.09%
Assets 1 -88.46 2,176 1,319 3,295 5,038 5,769 67,599 11,287
Book Value Per Share 2 0.1600 - 1.250 9.120 6.060 6.750 7.280 8.150
Cash Flow per Share 2 - - 0.9900 -0.0300 0.7500 0.6000 1.150 1.260
Capex 1 61 49.3 51.7 93.5 103 120 139 153
Capex / Sales 5.14% 3.88% 3.51% 5.18% 4.55% 4.6% 4.77% 4.76%
Announcement Date 2/20/20 2/18/21 2/17/22 2/16/23 2/27/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for R1 RCM Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
12.86 USD
Average target price
16.79 USD
Spread / Average Target
+30.53%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
R1 RCM INC. Stock R1 RCM Inc.
+21.67% 5.42B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+25.52% 88.99B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-24.52% 74.82B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
-1.76% 25.03B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+4.31% 17.88B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-14.25% 16.43B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+2.97% 15.77B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+79.20% 13.21B
NATERA, INC. Stock Natera, Inc.
+70.11% 13.08B
DAVITA INC. Stock DaVita Inc.
+40.44% 12.9B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. RCM Stock
  4. Financials R1 RCM Inc.